메뉴 건너뛰기




Volumn 29, Issue 19, 2011, Pages 3610-3616

HPV vaccination in France: Uptake, costs and issues for the National Health Insurance

Author keywords

Cervical cancer screening; Health insurance; Human papillomavirus; Reimbursement database; SNIIRAM; Vaccine

Indexed keywords

WART VIRUS VACCINE;

EID: 79955034694     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.064     Document Type: Article
Times cited : (64)

References (33)
  • 1
    • 33646058566 scopus 로고    scopus 로고
    • Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    • Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367:1247-1255.
    • (2006) Lancet , vol.367 , pp. 1247-1255
    • Harper, D.M.1    Franco, E.L.2    Wheeler, C.M.3    Moscicki, A.B.4    Romanowski, B.5    Roteli-Martins, C.M.6
  • 2
    • 34249689698 scopus 로고    scopus 로고
    • Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 viruslike particle (VLP) vaccine
    • Olsson S.E., Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Malm C., et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 viruslike particle (VLP) vaccine. Vaccine 2007, 25:4931-4939.
    • (2007) Vaccine , vol.25 , pp. 4931-4939
    • Olsson, S.E.1    Villa, L.L.2    Costa, R.L.3    Petta, C.A.4    Andrade, R.P.5    Malm, C.6
  • 3
    • 79955029503 scopus 로고    scopus 로고
    • Haute Autorité de santé - État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France - Argumentaire (French), ; [accessed 20.11.10].
    • Haute Autorité de santé - État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France - Argumentaire (French), ; [accessed 20.11.10]. http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/argumentaire_recommandations_depistage_cancer_du_col_de_luterus.pdf.
  • 4
    • 79955030847 scopus 로고    scopus 로고
    • Avis du Comité Technique des Vaccinations et du Conseil Supérieur d'Hygiène Publique de France, Section des Maladies Transmissibles, relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18 (French), 9 March [accessed 3.08.10].
    • Avis du Comité Technique des Vaccinations et du Conseil Supérieur d'Hygiène Publique de France, Section des Maladies Transmissibles, relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18 (French), 9 March 2007; [accessed 3.08.10]. http://www.hcsp.fr/docspdf/cshpf/a_mt_090307_papillomavirus.pdf.
    • (2007)
  • 5
    • 79955023457 scopus 로고    scopus 로고
    • Haut Conseil de la santé publique - Avis relatif à la vaccination contre les papillomavirus humains 16 et 18 par un vaccin bivalent (French), 14 December; [accessed 3.08.10].
    • Haut Conseil de la santé publique - Avis relatif à la vaccination contre les papillomavirus humains 16 et 18 par un vaccin bivalent (French), 14 December 2007; [accessed 3.08.10]. http://www.hcsp.fr/hcspi/docspdf/avisrapports/hcspa20071214_Papillomavirus.pdf.
    • (2007)
  • 6
    • 79955012423 scopus 로고    scopus 로고
    • Haut Conseil de la santé publique - Avis relatif à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23ans (French), 17 December; [accessed 26.01.11].
    • Haut Conseil de la santé publique - Avis relatif à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23ans (French), 17 December 2010; [accessed 26.01.11]. http://www.hcsp.fr/docspdf/avisrapports/hcspa20101217_ppmvjf1423.pdf.
    • (2010)
  • 7
    • 79955034108 scopus 로고    scopus 로고
    • L'assurance maladie en ligne - Statistiques et publications. MEDIC'AM(French), ; [accessed 20.11.10].
    • L'assurance maladie en ligne - Statistiques et publications. MEDIC'AM 2004-2009 (French), ; [accessed 20.11.10]. http://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/donnees-statistiques/medic-am-generic-am-biolam-lpp-am/medic-am-2004-2009.php.
    • (2004)
  • 8
    • 77649224129 scopus 로고    scopus 로고
    • Pharmacoepidemiological research using French reimbursement databases: yes we can!
    • Martin-Latry K., Bégaud B. Pharmacoepidemiological research using French reimbursement databases: yes we can!. Pharmacoepidemiol Drug Saf 2010, 19:256-265.
    • (2010) Pharmacoepidemiol Drug Saf , vol.19 , pp. 256-265
    • Martin-Latry, K.1    Bégaud, B.2
  • 10
    • 79955016010 scopus 로고    scopus 로고
    • National Institute of Statistics and Economic Studies, The French civil status statistics system, ; [accessed 3.08.10].
    • National Institute of Statistics and Economic Studies, The French civil status statistics system, ; [accessed 3.08.10]. http://www.insee.fr/en/themes/detail.asp%3Fref_id=ir-sd2005%26page=irweb/sd2005/dd/doc/source22.htm.
  • 11
    • 79955033778 scopus 로고    scopus 로고
    • National Institute of Statistics and Economic Studies.
    • National Institute of Statistics and Economic Studies Demographic balance sheet 2009, http://www.insee.fr/en/themes/theme.asp?theme=2&sous_theme=1; [accessed 3.08.10].
    • (2009) Demographic balance sheet
  • 12
    • 79954999157 scopus 로고    scopus 로고
    • European Medicines Agency, Gardasil: EPAR - Product Information. ; [accessed 3.08.10].
    • European Medicines Agency, Gardasil: EPAR - Product Information. ; [accessed 3.08.10]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000703/WC500021142.pdf.
  • 13
    • 79954999846 scopus 로고    scopus 로고
    • European Medicines Agency. Cervarix: EPAR - Product Information, ; [accessed 03.08.10].
    • European Medicines Agency. Cervarix: EPAR - Product Information, ; [accessed 03.08.10]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000721/WC500024632.pdf.
  • 14
    • 79954996526 scopus 로고    scopus 로고
    • European Cervical Cancer Association, HPV Vaccination Across Europe, ; [accessed 3.08.10].
    • European Cervical Cancer Association, HPV Vaccination Across Europe, ; [accessed 3.08.10]. http://www.ecca.info/fileadmin/user_upload/HPV_Vaccination/ECCA_HPV_Vaccination_April_2009.pdf.
  • 15
    • 70349256456 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2008, MMWR Morb Mortal Wkly Rep; 58: 997-1001, ; [accessed 03.08.10].
    • Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2008, MMWR Morb Mortal Wkly Rep 2009; 58: 997-1001, ; [accessed 03.08.10]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5836a2.htm.
    • (2009)
  • 16
    • 77955928840 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years - United States, 2009, MMWR Morb Mortal Wkly Rep
    • Centers for Disease Control and Prevention (CDC), National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years - United States, 2009, MMWR Morb Mortal Wkly Rep 2010; 59: 1018-23, ; [accessed 10.10.10]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5932a3.htm.
    • (2010) , vol.59 , pp. 1018-1023
  • 17
    • 79954998185 scopus 로고    scopus 로고
    • Department of Health, Annual HPV vaccine uptake in England: 2008/09, ; [accessed 03.08.10].
    • Department of Health, Annual HPV vaccine uptake in England: 2008/09, ; [accessed 03.08.10]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111676.pdf.
  • 18
    • 79954999844 scopus 로고    scopus 로고
    • HPV Vaccination Programme: Provisional data, as submitted by PCTs, for First and Second dose vaccine uptake, for the month ending 28 February [accessed 03.08.10].
    • HPV Vaccination Programme: Provisional data, as submitted by PCTs, for First and Second dose vaccine uptake, for the month ending 28 February 2010, ; [accessed 03.08.10]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_115153.pdf.
    • (2010)
  • 20
    • 79955038931 scopus 로고    scopus 로고
    • Conseil Supérieur D'hygiène Publique de France, Comité Technique Des Vaccinations, Groupe de Travail sur la vaccination contre les papillomavirus, 23 March final version (French). ; [accessed 03.08.10].
    • Conseil Supérieur D'hygiène Publique de France, Comité Technique Des Vaccinations, Groupe de Travail sur la vaccination contre les papillomavirus, 23 March 2007 final version (French). ; [accessed 03.08.10]. http://www.sante.gouv.fr/dossiers/cshpf/r_mt_230307_papillomavirus.pdf.
    • (2007)
  • 21
    • 79955025459 scopus 로고    scopus 로고
    • Modélisation médico-économique de l'impact de l'organisation du dépistage du cancer du col utérin et de l'introduction de la vaccination contre les HPV dans le calendrier vaccina
    • Dervaux B, Lenne X, Lévy-Bruhl D, Kudjawu Y. Modélisation médico-économique de l'impact de l'organisation du dépistage du cancer du col utérin et de l'introduction de la vaccination contre les HPV dans le calendrier vaccinal, Mars 2007 (French), ; [accessed 20.11.10]. http://www.invs.sante.fr/publications/2008/modelisation_hpv/rapport_modelisation_hpv.pdf.
    • Dervaux, B.1    Lenne, X.2    Lévy-Bruhl, D.3    Kudjawu, Y.4
  • 22
    • 0033947903 scopus 로고    scopus 로고
    • Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis
    • Myers E.R., McCrory D.C., Nanda K., Bastian L., Matchar D.B. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000, 151:1158-1171.
    • (2000) Am J Epidemiol , vol.151 , pp. 1158-1171
    • Myers, E.R.1    McCrory, D.C.2    Nanda, K.3    Bastian, L.4    Matchar, D.B.5
  • 23
    • 38549164676 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
    • Bergeron C., Largeron N., McAllister R., Mathevet P., Remy V. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France. Int J Technol Assess Health Care 2008, 24:10-19.
    • (2008) Int J Technol Assess Health Care , vol.24 , pp. 10-19
    • Bergeron, C.1    Largeron, N.2    McAllister, R.3    Mathevet, P.4    Remy, V.5
  • 24
    • 50849119746 scopus 로고    scopus 로고
    • Modeling cervical cancer prevention in developed countries
    • Kim J.J., Brisson M., Edmunds W.J., Goldie S.J. Modeling cervical cancer prevention in developed countries. Vaccine 2008, 26(Suppl. 10):K76-K86.
    • (2008) Vaccine , vol.26 , Issue.SUPPL. 10
    • Kim, J.J.1    Brisson, M.2    Edmunds, W.J.3    Goldie, S.J.4
  • 25
    • 44349147211 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
    • Szucs T.D., Largeron N., Dedes K.J., Rafia R., Bénard S. Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Curr Med Res Opin 2008, 24:1473-1483.
    • (2008) Curr Med Res Opin , vol.24 , pp. 1473-1483
    • Szucs, T.D.1    Largeron, N.2    Dedes, K.J.3    Rafia, R.4    Bénard, S.5
  • 26
    • 52949147772 scopus 로고    scopus 로고
    • Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
    • Usher C., Tilson L., Olsen J., Jepsen M., Walsh C., Barry M. Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model. Vaccine 2008, 26:5654-5661.
    • (2008) Vaccine , vol.26 , pp. 5654-5661
    • Usher, C.1    Tilson, L.2    Olsen, J.3    Jepsen, M.4    Walsh, C.5    Barry, M.6
  • 27
    • 49549088827 scopus 로고    scopus 로고
    • Economic evaluation of human papillomavirus vaccination in the United Kingdom
    • Jit M., Choi Y.H., Edmunds W.J. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008, 337:331-335.
    • (2008) BMJ , vol.337 , pp. 331-335
    • Jit, M.1    Choi, Y.H.2    Edmunds, W.J.3
  • 28
    • 77953554172 scopus 로고    scopus 로고
    • Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
    • Olsen J., Jepsen M.R. Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark. Int J Technol Assess Health Care 2010, 26:183-191.
    • (2010) Int J Technol Assess Health Care , vol.26 , pp. 183-191
    • Olsen, J.1    Jepsen, M.R.2
  • 29
    • 77952355761 scopus 로고    scopus 로고
    • Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types
    • Armstrong E.P. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm 2010, 16:217-230.
    • (2010) J Manag Care Pharm , vol.16 , pp. 217-230
    • Armstrong, E.P.1
  • 30
    • 77649271813 scopus 로고    scopus 로고
    • Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK
    • Cuzick J., Castañón A., Sasieni P. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer 2010, 102:933-939.
    • (2010) Br J Cancer , vol.102 , pp. 933-939
    • Cuzick, J.1    Castañón, A.2    Sasieni, P.3
  • 31
    • 79954987881 scopus 로고    scopus 로고
    • Vaccination coverage of children and adolescents in France: results of school-based surveys, (French), ; [accessed 20.11.10].
    • Antona D, Fonteneau L, Lévy-Bruhl D, Guignon N, De Peretti C, Niel X, et al. Vaccination coverage of children and adolescents in France: results of school-based surveys, 2001-2004 (French), ; [accessed 20.11.10]. http://www.invs.sante.fr/BEh/2007/06/beh_06_2007.pdf.
    • (2001)
    • Antona, D.1    Fonteneau, L.2    Lévy-Bruhl, D.3    Guignon, N.4    De Peretti, C.5    Niel, X.6
  • 33
    • 73749086154 scopus 로고    scopus 로고
    • Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program
    • Mehu-Parant F., Rouzier R., Soulat J.M., Parant O. Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program. Eur J Obstet Gynecol Reprod Biol 2010, 148:186-190.
    • (2010) Eur J Obstet Gynecol Reprod Biol , vol.148 , pp. 186-190
    • Mehu-Parant, F.1    Rouzier, R.2    Soulat, J.M.3    Parant, O.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.